Article
Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase.
The Journal of biological chemistry - 28 Oct 2011
Asim Mohammad, Hafeez Bilal Bin, Siddiqui Imtiaz Ahmad, Gerlach Claudia, Patz Michaela, Mukhtar Hasan, Baniahmad Aria
Abstract excerpt
The activated androgen receptor (AR) promotes prostate cancer (PCa) growth. AR antagonists repress the AR by recruitment of corepressors. Not much is known about the inactivation of AR by corepressors in the presence of agonists (androgens). Here we show that the corepressor LCoR acts as an androgen-dependent corepressor that represses human PCa growth in vivo. In line with this, progressive decrease of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
